Our aim was to elucidate the site and mechanism responsible for reactive hyperemia in coronary circulation. In in vivo beating canine hearts, microvessels of the left anterior descending coronary artery (LAD) were observed through a microscope equipped with a floating objective. Flow velocity of the LAD was measured with a suction-type Doppler probe. The LAD was occluded for 20 or 30 seconds and then released, and reactive hyperemia was observed before and after 8-phenyltheophylline (7.5 mg/kg i.v.) or glibenclamide (200 p,g/kg into the LAD) infusion. During the occlusion, only arterial microvessels smaller than 100 ptm in diameter dilated. Dilation of those vessels was partially attenuated by 8-phenyltheophylline and completely abolished with glibenclamide. In the early phase of reactive hyperemia, all arterial microvessels dilated, and the magnitude of peak dilation was greater in vessels smaller than 100 jum compared with those larger than 100 ,um. Vasodilation during reactive hyperemia ceased within 60 seconds in vessels smaller than 100 ,um but was sustained for more than 120 seconds in those larger than 100 p.m. 8-Phenyltheophylline did not change peak dilation of arterial microvessels but reduced dilation after the peak. Glibenclamide remarkably attenuated dilation of all arterial microvessels in the whole phase of reactive hyperemia. These results indicate that all arterial microvessels are responsible for reactive hyperemia after coronary artery occlusions of 20-30 seconds, but there is greater participation of vessels smaller than 100 p.m in the early phase of reactive hyperemia. Dilation of vessels larger than 100 ,um assumes an important role in the later phase. ATP-sensitive K' channels mediate dilation of arterial microvessels both in brief ischemia and reactive hyperemia. (Circulation Research 1992;71:912-922) KEY WORDS * coronary microcirculationadenosine eactive hyperemia is a ubiquitous phenomenon in many organs and in the coronary circulation.1-3 This phenomenon has been used to estimate coronary flow reserve in experimental45 and clinical67 studies. Nevertheless, the site and mechanism regulating reactive hyperemia are still unknown. We previously reported that the site responsible for autoregulation and active hyperemia differ in the coronary microcirculation.89 In those studies, only coronary arterial microvessels smaller than 100 ,um in diameter dilated when perfusion pressure was reduced, and arterial microvessels smaller than 380 ,um dilated when metabolic demand was increased. Because the site responsible for these two dominant local coronary controls differs, it is important to know the site responsible for reactive hyperemia to evaluate coronary flow reserve by using this phenomenon. In addition, several
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The epimyocardium of the left ventricle (left anterior descending coronary artery [LAD] area) was transilluminated using an optical fiber and a xenon arc lamp. The optical fiber (0.6 mm in diameter), which was mounted in the lumen of a 20-gauge stainless-steel needle, was introduced into the midmyocardium. The needle was attached to a needle holder that allowed its tip to move up and down in unison with the cardiac motion. To adjust the focal distance between the heart and the floating lens, the floating lens was lifted just above the surface of the heart by an arm connected to the needle holder.
The microscope objective used for this study was Leitz model PL-fl (x 10; N.A., 0.30). Images obtained with the microscope were stored on a magnetic tape with a high-speed video system (model MHS-200, Nac Inc., Tokyo) at 200 frames per second. The time of each frame was recorded on each video frame for correlation with hemodynamics. These stored images were then analyzed on a video monitor (model V-44, Nac) by using an X-Y coordinator (model MHS-200, Nac) and/or on printed images by a video-graphic printer (model UP-811, Sony, Tokyo). The sites of vessels where we measured the diameters were identified by using reference points such as the branching point of vessels.
General Preparation
Mongrel dogs (n=36) of either sex weighing 2.8-7.7 kg were sedated with ketamine (20 mg/kg i.m.) and then anesthetized with a-chloralose (50 mg/kg a-chloralose plus 50 mg/kg sodium borate i.v. 
Responses of LAD Flow and Coronary Arterial Microvessels During 20 Seconds of LAD Occlusion and Reactive Hyperemia
During reactive hyperemia after 20 seconds of LAD occlusion, peak LAD flow was observed approximately 5 seconds after the release of the snare (Figure 2 ). LAD flow then gradually declined but was sustained for more than 120 seconds (Figure 3a) . Coronary arterial microvessels of all dogs (n = 26) that received 20 seconds of LAD occlusion were divided into three sizes according to control diameters: small (67+±4 ,tm in diameter; range, 38-98 gm; n =22 vessels), medium (133 ±7 ,m in diameter; range, 100-199 gm; n = 16 vessels), and large (250±13 gm in diameter; range, 205-313 ,um; n=8 vessels). Diameters of all vessels decreased 4 seconds after the start of occlusion, and 18 seconds after the start of occlusion, only the small vessels dilated ( Figure  3b ). When the snare was released, all vessels quickly dilated, and peak dilation was observed 3-7 seconds later ( Figure 4 ). The magnitude of peak dilation was greater in the small vessels than in the others. Diameters of small vessels returned to the control value within 60 seconds, but dilation of medium and large vessels was sustained for more than 120 seconds (Figure 3b) (Figures 2, 5a, and 6a) . Because re- (Figures 7a  and 8a ). Arterial microvessels were also divided into two sizes: small and medium+large, i.e., small (62±6 gtm in diameter; range, 38-84 ,um; n=8 vessels) and medium+large (180+20 ,um in diameter; range, 106-313 ,um; n=12 vessels) in the group that received 20 seconds of LAD occlusion (n = 12 dogs) and small (71 ±6 gm in diameter; range, 45-87 ,um; n=7 vessels) and medium+large (208±39 gm in diameter; range, 142-400 ,um; n=6 vessels) in the group that received 30 seconds of LAD occlusion (n=5 dogs). In both groups, glibenclamide almost abolished the dilation of small vessels during LAD occlusion and significantly attenuated peak dilation of vessels of all sizes during reactive hyperemia (Figures 7b and 8b) . At . Effect ofglibenclamide (GC) on responses ofleft anterior descending coronary artery (LAD) flow and coronary arterial microvessels during 20 seconds of ischemia and reactive hyperemia (RH). ID, internal diameter. Vessels were divided as described in the legend of Figure 5 . LAD flow and diameters were expressed as described in the legend ofFigure 3. Panel a: Graph shows that LAD flow during RH was not altered at the peak but was strikingly reduced at 15, 30, 60, and 120 seconds by GC. Panel b: Bar graphs show that, during 20 seconds of ischemia, GC completely abolished the dilation of small vessels and that peak dilation during RH was one third in small vessels and half in the medium+large vessels in the presence of GC. Also, GC strikingly suppressed or nearly abolished 2) the dilation of vessels of all sizes after the peak. seconds during reactive hyperemia, dilation of vessels of all sizes was significantly attenuated or almost abolished in the presence of glibenclamide in both groups (Figures  7b and 8b) .
Discussion
This study further clarified the sites and the mechanisms responsible for reactive hyperemia in the coronary circulation. Accordingly, there are several important observations. Within 20-30 seconds of flow arrest, arterial microvessels smaller than 100 ,gm in diameter dilate. The dilation is partially attenuated by 8-phenyltheophylline in the early phase and almost abolished by glibenclamide in the whole phase. During reactive hyperemia, arterial microvessels of all sizes dilate, but greater peak dilation occurs in small vessels (< 100 ,um) than in medium+large vessels (> 100 ,um). The duration of dilation is longer in medium+large vessels than in small vessels. 8-Phenyltheophylline does not change peak dilation but attenuates the dilation after the peak. Glibenclamide strikingly suppresses the dilation of all arterial microvessels in the whole phase of reactive hyperemia.
Critique of Methods
In the present study, a floating objective was used for the observation of the coronary microcirculation. 18, 19 In this method, mechanical factors that may affect the coronary microcirculation were eliminated to the extent possible. However, the light-conducting needle inserted into the myocardium may cause microtrauma and a change in intramyocardial pressure. However, other investigators have suggested that this point is of little importance. 24 stimuli. The response of coronary flow to adenosine was similar before and after glibenclamide infusion, suggesting that there was no fixed disorder of the relaxation mechanism in the vascular smooth muscle. However, this result does not preclude the possibility that adenosine can open ATP-sensitive K' channels.17 Because, in the present study, glibenclamide was infused as a bolus into the LAD and adenosine was examined at the end of the experiment (25 minutes later), the effect of glibenclamide may have been reduced when adenosine was infused.
Role ofAdenosine and ATP-Sensitive K' Channels in the Responses of Coronary Arterial Microvessels to Brief Ischemia During LAD occlusion, arterial microvessels smaller than 100 gm in diameter dilated within 18 seconds.
Glibenclamide almost completely abolished the dilation at 18 and 28 seconds, and 8-phenyltheophylline partially attenuated the dilation at only 18 seconds. These results suggest that the dilation of small vessels during ischemia was mostly mediated by ATP-sensitive K' channels and that adenosine may dilate those vessels in part via ATP-sensitive K' channels only at the early phase. It is uncertain whether the opening of ATP-sensitive K' channels is regulated by the reduced ATP levels in smooth muscle. It has been reported that the ATP level of the myocardium, which has high energy consumption, did not change during 24 seconds of coronary occlusion.34 Therefore, the ATP level in smooth muscle may not decrease during 20-30 seconds of ischemia. One possible explanation could be the existence of compartmentalized pools of intracellular ATP governed by anaerobic metabolism-using key glycolytic enzymes. 35 Another possibility is that the opening probability of ATP-sensitive K' channels may relate to the change in distending pressure. In isolated coronary arterial microvessels, potent myogenic response has been observed in vessels smaller than 100 gam in diameter36 but was absent in vessels larger than 200 ,gtm.37 Therefore, it is conceivable that the dilation of small vessels relates to the lowered transmural pressure. In addition, a proportional depolarization of vascular smooth muscle to increased transmural pressure has been observed in the small renal arteries.38
Responses of Coronary Arterial Microvessels During Reactive Hyperemia and the Role of Adenosine and ATP-Sensitive K' Channels The present study indicates that dilation of vessels of all sizes is responsible for reactive hyperemia. Dilation of small vessels assumes a more important role in the earlier phase of reactive hyperemia, and dilation of large vessels assumes an important role in the late phase. In both groups that received 20 and 30 seconds of ischemia, 8-phenyltheophylline did not alter the flow and vasodilation at the peak but attenuated both at 15, 30, and 60 seconds. As shown in Figures 5 and 6 , reduction in the repayment area by 8-phenyltheophylline was greater in the group that received 30 seconds of ischemia. These results were consistent with previous reports.39 ' 40 When ATP-sensitive K' channels were blocked with glibenclamide, dilation of arterial microvessels was strikingly suppressed throughout the whole phase of reactive hyperemia. Coronary flow was also significantly attenuated except for the peak flow. The discrepancy between flow and diameter change at the peak may be explained by the effect of coronary capacitance; i.e., coronary flow just after release of the snare may be caused by the blood that fills the collapsed vessels. Such an effect of capacitance may also explain why aminophylline failed to suppress the repayment area in reactive hyperemia after very short ischemia. 41 The increased blood flow after very short ischemia may be caused by the change in capacitance and not by vasodilation. Present data suggest that peak vasodilation was not mediated by adenosine but mostly by ATP-sensitive K' channels. ATP-sensitive K' channels govern most responses of coronary arterial microvessels throughout the whole phase of reactive hyperemia, and adenosine also plays some role in the phase following the peak of reactive hyperemia. The present data may also explain why hypercapnic acidosis enhances the reactive hyperemic response after long periods of ischemia,42 because a decrease in intracellular pH reduces the inhibitory effect of ATP on ATP-sensitive K' channels in the skeletal muscle. 43 Changes in intracellular pH may also have a similar effect on these channels in the coronary circulation.
